Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.96−0.01 (-0.51%)
Close on Nov 13, 2026Market cap $609.23MP/E –Yield 0.00%
Pacific Biosciences of California ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2018 it was -$93.77M. The highest annual figure on record is -$25.46M in fiscal 2015.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | -$93.77M | – |
| FY2017 | Dec 31, 2017 | -$81.34M | – |
| FY2016 | Dec 31, 2016 | -$67.37M | – |
| FY2015 | Dec 31, 2015 | -$25.46M | – |
| FY2014 | Dec 31, 2014 | -$58.63M | – |
| FY2013 | Dec 31, 2013 | -$71.90M | – |
| FY2012 | Dec 31, 2012 | -$87.69M | – |
| FY2011 | Dec 31, 2011 | -$103.95M | – |
See a number that looks wrong?